Behind the markets

Daily Trades

August 2024 Issue: ADC Therapeutics (ADCT) & Updates (EXEL,APLS,LLY,AGIO, RXRX)

Lots to discuss today, so I’m going to take them one at a time.
Learn More

July 2024 Issue: Apellis Pharmaceuticals (APLS)

Because small biotech stocks have sold off this year, the stock price doesn’t reflect the company’s business prospects, so I am banging the table again on this one.
Learn More

October 2023 Issue: Updates

The 30% sell-off in biotech stocks has given us the opportunity to buy things for the best prices I’ve seen all year.
Learn More

TRADE ALERT: Apellis up 30% on Safety Results

Learn More

August 2023 Issue: Apellis Pharmaceuticals (SYM: APLS)

Thirty years of investing has taught me that when it’s time to sell, it’s time to sell. There’s no point in crying about it.
Learn More

UPDATE: Apellis meets “The Fugitive”?

In April, we sold half of our shares in Apellis Pharmaceuticals, Inc (SYM: APLS) at $85, a 76% increase from our recommended price of $48.42. 
Learn More

July 2023 Issue: Amicus Therapeutics Inc. (SYM: FOLD)

Learn More

June 2023 Issue: 3 Stocks Riding the Weight Loss Wave – (LLY), (NVO), (VKTX)

Let's start by closing out one of our older positions for a small profit. 
Learn More

TRADE ALERT: Lock in some profits on Apellis

I recommend selling half your shares in Apellis Pharmaceuticals, Inc (SYM: APLS)
Learn More

March 2023 Issue: Schrodinger (SYM: SDGR)

A.I. has started to revolutionize drug discovery. You see, right now there are a about 6,000 genetic diseases known to mankind – Liver Disease…Diabetes…Skin Cancer...Heart Disease… You name it. 
Learn More

deal of the month

best growth stocks

Alliance

Bundle package – lifetime subscriptions for all products

Get Deal

Categories

Behind the Markets

3.1K subscribers

Independent Research for Independent Investors

Behind the Markets
This morning, I want to talk about something I believe could shake the financial markets to their core—President Trump's escalating attempts to replace Federal Reserve Chair Jerome Powell. While I’m generally a supporter of the unitary executive theory, which gives the president broad powers, this is one place where I draw the line. History shows us exactly what happens when the Fed loses its independence—and none of it is good. We’re already seeing signs of market jitters. A simple leaked conversation where Trump floated the idea of firing Powell caused the U.S. dollar to drop 1.2% in minutes. Think about that—your dollar lost value in real time. Mortgage rates, treasury yields, and the S&P all reacted. It’s not just theory. This stuff matters, and it hits your wallet directly. Back in the '70s, Nixon pressured Fed Chair Arthur Burns and the result was a historic inflation crisis that took Paul Volcker years to fix. We cannot afford to make that mistake again. If we start treating the Fed Chair like a cabinet appointment, it opens the door for any future president—on the left or right—to hijack monetary policy. That’s a dangerous game to play with your savings, your mortgage, and the value of the U.S. dollar. So before we all nod our heads at the idea of swapping out Powell for someone more “friendly,” we really need to pause and ask: what does that do to American credibility, stability, and the long-term health of the economy? Spoiler: nothing good. ✅ SUBSCRIBE TO THE CHANNEL 👇🏼👇🏼 https://www.youtube.com/channel/UCczJ4YRRQLl6KrH06iapaRw?sub_confirmation=1 ✅ SIGN UP FOR DYLAN'S DIARY HERE 👇🏼👇🏼 https://go.behindthemarkets.com/dylans-diary-sign-up/ ✅ VISIT OUR WEBSITE 👇🏼👇🏼 https://behindthemarkets.com/
YouTube Video VVVjeko0WVJSUUxsNktySDA2aWFwYVJ3LktsdDIyOHVVV3lj

Dylan Jovine | Firing Powell: A Market Disaster in the Making

I’m back—and better than ever! After spending some time in Europe with my family, teaching my kids about the foundations of Western civilization, I came home to some powerful headlines. One story that really jumped out was from Barron’s, quoting Defense Secretary Pete Hegseth. His announcement about cutting red tape to unleash American manufacturing in the defense sector is music to my ears—and great news for us as investors. While I was trying to unplug (rare for me), I couldn’t help but notice the market reaction. Drone stocks like Kratos and AeroVironment jumped sharply—Kratos is now up 97% from our recommended price, and AeroVironment is up 115%. This is the kind of shift we’ve been preparing for. The Pentagon is finally starting to move faster, and it's giving new life to small defense contractors who were previously shut out by a painfully slow approval process. But here’s what most people missed: this isn’t just an American story. Europe is seeing the same renaissance in defense spending, and that opens the door to a second wave of opportunity. We’ve put together a special report highlighting the top American and European defense stocks still flying under the radar—but not for long. As always, I’m grateful to be back with you. This is a truly exciting time for investors who understand the future of warfare is distributed, intelligent, and autonomous. Make sure you don’t miss this moment. ✅ SUBSCRIBE TO THE CHANNEL 👇🏼👇🏼 https://www.youtube.com/channel/UCczJ4YRRQLl6KrH06iapaRw?sub_confirmation=1 ✅ SIGN UP FOR DYLAN'S DIARY HERE 👇🏼👇🏼 https://go.behindthemarkets.com/dylans-diary-sign-up/ ✅ VISIT OUR WEBSITE 👇🏼👇🏼 https://behindthemarkets.com/
YouTube Video VVVjeko0WVJSUUxsNktySDA2aWFwYVJ3LlBwa3lXZkl5cE8w

Dylan Jovine | New Era of Warfare = New Wealth

Good morning — Dylan Jovine here with Behind the Markets. Lately, we’ve been diving deep into this monumental shift happening right before our eyes: the move from AI to what I call the EI era — Embodied Intelligence. It’s one thing to have AI on your screen, but it’s a whole different world when that intelligence jumps into physical form. Robots, smart devices, delivery bots — it’s all coming, and it’s going to change every corner of our lives. In today’s video, I broke down my personal top 7 ways robots are going to impact our daily routines, industries, and even our relationships. From home assistants that actually fold your laundry to fitness bots correcting your form, eldercare robots helping with medication, and even robotic pets offering companionship — it sounds like science fiction, but it’s already starting to happen. The EI era isn’t a theory anymore; it’s a business reality that’s going to hit fast and hard. And while some of these ideas still sound wild to me (I’ve seen too many Terminator movies to let a robot cook my dinner), there’s no denying which industries are going to adopt them first. The ones where they can save the most money. Warehousing, security, delivery — those are coming sooner than you think. In this episode, I explain exactly why, and how it all ties back to data centers and nuclear-powered infrastructure keeping it running. I also talk about how companies like Tesla are already using embodied intelligence today, and why this shift is going to unlock entirely new markets. If you haven’t checked out our brand new video and report on EI, make sure you do. This is one of the biggest investment opportunities I’ve seen in 20 years — and you’ll want to be ahead of it. ✅ SUBSCRIBE TO THE CHANNEL 👇🏼👇🏼 https://www.youtube.com/channel/UCczJ4YRRQLl6KrH06iapaRw?sub_confirmation=1 ✅ SIGN UP FOR DYLAN'S DIARY HERE 👇🏼👇🏼 https://go.behindthemarkets.com/dylans-diary-sign-up/ ✅ VISIT OUR WEBSITE 👇🏼👇🏼 https://behindthemarkets.com/
YouTube Video VVVjeko0WVJSUUxsNktySDA2aWFwYVJ3Ljc0QldaU3FIejNr

Dylan Jovine | The Future of EI: Robots Will Change Our Lives

Load More... Subscribe

Recent posts

The Next Tesla? These Air Mobility Stocks Are Up Nearly 300% – 7/18

Dollar plummets on leaked story

Protect Your Portfolio with High-Yielding Stocks

The Next Big Megatrend?? – 7/17

Tags

Connect with Us

Icon-facebook Icon-btmshare_tw

August 2024 Issue: ADC Therapeutics (ADCT) & Updates (EXEL,APLS,LLY,AGIO, RXRX)

Lots to discuss today, so I’m going to take them one at a time.
Learn More

July 2024 Issue: Apellis Pharmaceuticals (APLS)

Because small biotech stocks have sold off this year, the stock price doesn’t reflect the company’s business prospects, so I am banging the table again on this one.
Learn More

October 2023 Issue: Updates

The 30% sell-off in biotech stocks has given us the opportunity to buy things for the best prices I’ve seen all year.
Learn More

TRADE ALERT: Apellis up 30% on Safety Results

Learn More

August 2023 Issue: Apellis Pharmaceuticals (SYM: APLS)

Thirty years of investing has taught me that when it’s time to sell, it’s time to sell. There’s no point in crying about it.
Learn More

UPDATE: Apellis meets “The Fugitive”?

In April, we sold half of our shares in Apellis Pharmaceuticals, Inc (SYM: APLS) at $85, a 76% increase from our recommended price of $48.42. 
Learn More

July 2023 Issue: Amicus Therapeutics Inc. (SYM: FOLD)

Learn More

June 2023 Issue: 3 Stocks Riding the Weight Loss Wave – (LLY), (NVO), (VKTX)

Let's start by closing out one of our older positions for a small profit. 
Learn More

TRADE ALERT: Lock in some profits on Apellis

I recommend selling half your shares in Apellis Pharmaceuticals, Inc (SYM: APLS)
Learn More

March 2023 Issue: Schrodinger (SYM: SDGR)

A.I. has started to revolutionize drug discovery. You see, right now there are a about 6,000 genetic diseases known to mankind – Liver Disease…Diabetes…Skin Cancer...Heart Disease… You name it. 
Learn More

Get FREE Daily Stock Tips

Join and receive market insider stock picks, trade alerts and unique investing insights
This field is for validation purposes and should be left unchanged.
By clicking the "Subscribe" button you are accepting our Terms of Use and Privacy Policy.
Behind the markets

Company

Explore

CUSTOMER SERVICE

  • We’re here to help.
    Contact Us:
    Mon – Fri | 10 AM – 7 PM EST
  • 1-800-851-1965

© 2025 Behind the Markets, LLC. All rights reserved.

Join Waitlist

We’re sorry, but due to the popularity of our services, we have reached our max number of subscribers and are not currently accepting more. If spots become available, we will be sure to contact you. Please join the waitlist below.
Thank You!

"*" indicates required fields

Name*
This field is for validation purposes and should be left unchanged.